ADC Therapeutics SA

Renewed interest in ADCs will continue in 2024

by

Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to the treatments to fuel growth in the year ahead. … Read more

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen

by

Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion.  Shares of ImmunoGen closed nearly 83% higher Thursday, while AbbVie’s stock closed almost 3% higher. … Read more